Current status of non-surgical treatment of locally advanced pancreatic cancer

World J Gastrointest Oncol. 2021 Dec 15;13(12):2064-2075. doi: 10.4251/wjgo.v13.i12.2064.

Abstract

Pancreatic cancer is the 7th leading cause of death due to cancer in industrialized countries and the 11th most common cancer globally, with 458918 new cases (2.5% of all cancers) and 432242 deaths (4.5% of all cancer deaths) in 2018. Unfortunately, 80% to 90% of the patients present with unresectable disease, and the reported 5-year survival rate range between 10% and 25%, even after successful resection with tumor-free margins. Systemic chemotherapy, radiotherapy, and minimally invasive image-guided procedures that have emerged over the past years, are used for the management of non-operable PC. This review focuses on currently available non-surgical options of locally advanced pancreatic cancer.

Keywords: Ablation; Interventional radiology; Oncology; Pancreatic cancer; Radiotherapy.

Publication types

  • Review